Delivery Order SPE2DB20D3103-SPE2DB24FL6W0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.70 firm fixed-price delivery order contract is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 31, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,569.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 30 mg/mL vials, a pain management medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999.00. The IDC enables...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ketorolac 30mg/ml 25s, a pain medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,029.16, is a firm fixed-price delivery order contract with a completion date of December 12, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Ketorolac 30 mg/ml vials, a medication used for pain management. The $1,985.51 firm-fixed price delivery order is part of a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that runs through November 2026. This IDC enables Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,016.51 Firm Fixed Price Delivery Order covers the supply of 4566583230 KETOROLAC 30 MG/ML VIALML, a specialized medication. The contract has an ultimate completion date of December 3, 2024 and was awarded on December 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $3,180.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 30 mg/ml vials, a pain management medication, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,453.20 firm fixed-price delivery order is for the supply of 30 mg/mL ketorolac vials, a medication used for pain management. The contract has a completion date of December 8, 2023 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,607.40. The order is for the supply of KETOROLAC 30 MG/ML VIALML, a medication, to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999,...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.07 firm fixed-price delivery order is for KETOROLAC 30 MG/ML VIALML, a generic pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,124.88 firm-fixed-price delivery order is for the supply of Ketorolac 30 mg/mL vials, a non-steroidal anti-inflammatory drug. This contract does not have a set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL6W0Delivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,848.11 fixed-price contract is for the supply of Ketorolac 15 mg/mL vials, a medication used for pain management, to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 11/28/23 |